Idiopathic Pulmonary Fibrosis and Progressive Pulmonary Fibrosis - Clinical Practice Guideline
Idiopathic Pulmonary Fibrosis and Progressive Pulmonary Fibrosis - Clinical Practice Guideline
This clinical practice guideline document from the American Thoracic Society, European Respiratory Society, Japanese Respiratory Society, and Asociacion Latinoamericana de Torax updates prior guidelines for idiopathic pulmonary fibrosis (IPF) and addresses the progression of pulmonary fibrosis in patients with interstitial lung diseases (ILDs) other than IPF.
The guidelines include, but are not limited to:
- Diagnosing and treating IPF
- The radiological features of usual interstitial pneumonia (UIP), the hallmark of IPF
- The histopathological features of UIP used in diagnosis
- Evidence-based recommendations for diagnosing IPF
- Updates to the 2018 guidelines for diagnosing IPF
- Evidence-based recommendations for the treatment of IPF
- The diagnosis and treatment of PPF in fibrotic ILD, including a definition of PPF
- Physiological criteria for PPF
- Radiological criteria for PPF
- Evidence-based recommendations for the treatment of PPF
Related Resources
Chronic Fibrosing ILD with Progressive Phenotype - HCP Resource
Diagnosis of HP in Adults - Clinical Practice Guideline
Guidelines from the American Thoracic Society offering a systematic approach to diagnosing hypersensitivity pneumonitis (HP).
View Resource
Chronic Fibrosing ILD with Progressive Phenotype - HCP Resource
Autoimmune Disease-Associated Interstitial Lung Disease - Slide Deck
Review autoimmune connective tissue disorders (CTDs) associated with ILD.
View Resource
Chronic Fibrosing ILD with Progressive Phenotype - HCP Resource
Hypersensitivity Pneumonitis - Slide Deck
Discover the characteristics, epidemiology, and pathogenesis of HP.
View Resource
